LCM Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-928
| Closed | -$215K | – | 97 |
|
2024
Q2 | $215K | Buy |
+928
| New | +$215K | 0.13% | 83 |
|
2024
Q1 | – | Sell |
-924
| Closed | -$239K | – | 94 |
|
2023
Q4 | $239K | Sell |
924
-4
| -0.4% | -$1.04K | 0.17% | 75 |
|
2023
Q3 | $239K | Buy |
928
+40
| +5% | +$10.3K | 0.19% | 75 |
|
2023
Q2 | $253K | Buy |
888
+7
| +0.8% | +$1.99K | 0.21% | 72 |
|
2023
Q1 | $245K | Buy |
881
+43
| +5% | +$12K | 0.21% | 71 |
|
2022
Q4 | $232K | Buy |
838
+4
| +0.5% | +$1.11K | 0.23% | 74 |
|
2022
Q3 | $223K | Buy |
+834
| New | +$223K | 0.24% | 68 |
|
2021
Q4 | – | Sell |
-798
| Closed | -$226K | – | 97 |
|
2021
Q3 | $226K | Sell |
798
-9
| -1% | -$2.55K | 0.19% | 77 |
|
2021
Q2 | $279K | Sell |
807
-12
| -1% | -$4.15K | 0.23% | 66 |
|
2021
Q1 | $229K | Sell |
819
-56
| -6% | -$15.7K | 0.2% | 74 |
|
2020
Q4 | $209K | Buy |
+875
| New | +$209K | 0.2% | 71 |
|